Down Syndrome

Allison Caban-Holt; Elizabeth Head; Frederick Schmitt

doi:10.1016/B978-0-12-410529-4.00015-2

Down Syndrome

Allison Caban-Holt, Elizabeth Head, Frederick Schmitt

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

8 Scopus citations

Abstract

Down syndrome (DS), or trisomy 21, is one of the most common causes of intellectual disability (ID) and recent prevalence estimates suggest that there are 11.8 to 14.47 per 10,000 live births in the United States with DS. It is estimated that 250,000 people in the United States have DS. In turn, World Health Organization estimates for DS range between 10 to 11 in 10,000 live births worldwide. This chapter summarizes current knowledge on DS risk and prevalence, behavioral, psychiatric, physical, and neurological manifestations of the disease, and the effects of aging on cognitive functioning of individuals with DS. Potential early indicators of Alzheimer disease in DS and recommendations for complete evaluation of dementia in individuals with ID are provided.

Original language	English
Title of host publication	Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease
Subtitle of host publication	Fifth Edition
Pages	163-170
Number of pages	8
ISBN (Electronic)	9780124105294
DOIs	https://doi.org/10.1016/B978-0-12-410529-4.00015-2
State	Published - Nov 13 2014

Bibliographical note

Publisher Copyright:
© 2015 Elsevier Inc. All rights reserved.

Keywords

Alzheimer disease
Cognition
Comorbidities
Down syndrome
Lifespan
Prevalence
Trisomy 21

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/B978-0-12-410529-4.00015-2

Cite this

@inbook{4c7374506c964873963517882cbff2a0,

title = "Down Syndrome",

abstract = "Down syndrome (DS), or trisomy 21, is one of the most common causes of intellectual disability (ID) and recent prevalence estimates suggest that there are 11.8 to 14.47 per 10,000 live births in the United States with DS. It is estimated that 250,000 people in the United States have DS. In turn, World Health Organization estimates for DS range between 10 to 11 in 10,000 live births worldwide. This chapter summarizes current knowledge on DS risk and prevalence, behavioral, psychiatric, physical, and neurological manifestations of the disease, and the effects of aging on cognitive functioning of individuals with DS. Potential early indicators of Alzheimer disease in DS and recommendations for complete evaluation of dementia in individuals with ID are provided.",

keywords = "Alzheimer disease, Cognition, Comorbidities, Down syndrome, Lifespan, Prevalence, Trisomy 21",

author = "Allison Caban-Holt and Elizabeth Head and Frederick Schmitt",

year = "2014",

month = nov,

day = "13",

doi = "10.1016/B978-0-12-410529-4.00015-2",

language = "English",

isbn = "9780124105492",

pages = "163--170",

booktitle = "Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease",

}

TY - CHAP

T1 - Down Syndrome

AU - Caban-Holt, Allison

AU - Head, Elizabeth

AU - Schmitt, Frederick

PY - 2014/11/13

Y1 - 2014/11/13

N2 - Down syndrome (DS), or trisomy 21, is one of the most common causes of intellectual disability (ID) and recent prevalence estimates suggest that there are 11.8 to 14.47 per 10,000 live births in the United States with DS. It is estimated that 250,000 people in the United States have DS. In turn, World Health Organization estimates for DS range between 10 to 11 in 10,000 live births worldwide. This chapter summarizes current knowledge on DS risk and prevalence, behavioral, psychiatric, physical, and neurological manifestations of the disease, and the effects of aging on cognitive functioning of individuals with DS. Potential early indicators of Alzheimer disease in DS and recommendations for complete evaluation of dementia in individuals with ID are provided.

AB - Down syndrome (DS), or trisomy 21, is one of the most common causes of intellectual disability (ID) and recent prevalence estimates suggest that there are 11.8 to 14.47 per 10,000 live births in the United States with DS. It is estimated that 250,000 people in the United States have DS. In turn, World Health Organization estimates for DS range between 10 to 11 in 10,000 live births worldwide. This chapter summarizes current knowledge on DS risk and prevalence, behavioral, psychiatric, physical, and neurological manifestations of the disease, and the effects of aging on cognitive functioning of individuals with DS. Potential early indicators of Alzheimer disease in DS and recommendations for complete evaluation of dementia in individuals with ID are provided.

KW - Alzheimer disease

KW - Cognition

KW - Comorbidities

KW - Down syndrome

KW - Lifespan

KW - Prevalence

KW - Trisomy 21

UR - http://www.scopus.com/inward/record.url?scp=84943226268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943226268&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-410529-4.00015-2

DO - 10.1016/B978-0-12-410529-4.00015-2

M3 - Chapter

AN - SCOPUS:84943226268

SN - 9780124105492

SP - 163

EP - 170

BT - Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease

ER -

Down Syndrome

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this